Wessex Neurological Centre, Southampton General Hospital, Southampton, SO9 4XY, UK.
J Psychopharmacol. 1987 Jan;1(1):31-4. doi: 10.1177/026988118700100107.
Electroencephalograms, recorded before and after 4 weeks' treatment with parox etine or placebo, were assessed blind to patient, treatment and treatment interval. No signifi cant differences were found between the paroxetine and the placebo groups. There were no signs of drowsiness or epileptiform activity in the recordings of patients receiving either drug or placebo. The results are discussed in relation to those of pharmacological studies in animals, psychomotor testing and electroencephalographic studies in humans.
对接受帕罗西汀或安慰剂治疗 4 周前后的脑电图进行了盲法评估,评估时不考虑患者、治疗和治疗间隔。帕罗西汀组和安慰剂组之间未发现显著差异。接受任何药物或安慰剂治疗的患者的记录中均未出现嗜睡或癫痫样活动迹象。结果与动物药理学研究、精神运动测试和人类脑电图研究的结果进行了讨论。